Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mery Zucchini"'
Autor:
Paola Guglielmelli, Margherita Massa, Tiziano Barbui, Giovanni Barosi, Umberto Arena, Silvia Betti, Alessandro Castellani, Alessandro M. Vannucchi, Lucia Merli, Rajmonda Fjerza, Maria Luisa Ferrari, Marco Ruggeri, Giuseppe Cimino, Ilaria Nichele, Arianna Masciulli, Mery Zucchini, Chiara Paoli, Mario Cazzola, Alessandro Rambaldi, Fabio Marra, Guido Finazzi, Stefano Colagrande, Tiziana Fanelli, Lisa Pieri, Vittorio Rosti, Carmela Mannarelli, Giuditta Corbizi Fattori, Valerio De Stefano, Fabio Mori, Elisa Rumi
Publikováno v:
American Journal of Hematology. 92:187-195
Splanchnic vein thrombosis (SVT) is one of the vascular complications of myeloproliferative neoplasms (MPN). We designed a phase 2 clinical trial to evaluate safety and efficacy of ruxolitinib in reducing splenomegaly and improving disease-related sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb06e4254cca3e6b8c663c7e6365ea8
https://doi.org/10.1002/ajh.24614
https://doi.org/10.1002/ajh.24614
Autor:
Salvatore Mario Romano, Marco Chiostri, Mery Zucchini, Serafina Valente, Chiara Lazzeri, Eleonora Tommasi, Andrea Sori, Gian Franco Gensini, Pasquale Bernardo
Publikováno v:
Acute Cardiac Care. 16:67-73
Data on the hemodynamic and cardiovascular effects of hypothermia in patients with cardiac arrest are scarce. The aim of this study was to evaluate the hemodynamic changes induced by hypothermia by means of Most Care(®) (pressure recording analytica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5763723c4b3342967042ea51cc51655e
https://doi.org/10.3109/17482941.2014.889310
https://doi.org/10.3109/17482941.2014.889310
Autor:
Marco Chiostri, Serafina Valente, Gian Franco Gensini, Cristina Giglioli, Chiara Lazzeri, Mery Zucchini
Publikováno v:
International journal of cardiology. 146(2)
The Intra-aortic Balloon Pump (IABP) is currently the most commonly used mechanical assist device to improve and support hemodynamics in patients with cardiogenic shock; it is widely used also in high-risk patients undergoing percutaneous coronary in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb02e84dd33c88898f771e1ad8ac364
https://pubmed.ncbi.nlm.nih.gov/21093943
https://pubmed.ncbi.nlm.nih.gov/21093943
Autor:
Tiziano Barbui, Giovanni Barosi, Ilaria Nichele, Lisa Pieri, Stefano Colagrande, Paola Guglielmelli, Vittorio Rosti, Carmela Mannarelli, Lucia Merli, Rajmonda Fjerza, Tiziana Fanelli, Mario Cazzola, Maria Luisa Ferrari, Alessandro M. Vannucchi, Guido Finazzi, Alessandro Castellani, Marco Ruggeri, Silvia Betti, Mery Zucchini, Fabio Marra, Margherita Massa, Valerio De Stefano, Fabio Mori, Arianna Masciulli, Chiara Paoli, Umberto Arena, Elisa Rumi, Giuseppe Cimino, Alessandro Rambaldi
Publikováno v:
Blood. 126:2803-2803
Background: Philadelphia-negative Myeloproliferative Neoplasms (MPN) include Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis, both Primary (PMF) and secondary to PV or ET (PPV-MF and PET-MF). A MPN is frequently the underlyin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96bebd064247ad0075cba3f5ad656b6c
https://doi.org/10.1182/blood.v126.23.2803.2803
https://doi.org/10.1182/blood.v126.23.2803.2803